Monday, April 13, 2026
Today's Print

Tag: Moderna

COVID-19: As lab execs sell shares worth millions, questions arise

Pfizer, Moderna, Novavax: executives at several American laboratories developing COVID-19 vaccines have recently pocketed millions of dollars by selling shares in their companies --...

US agency wants 2 months safety data before approving Covid-19 vaccine

The US Food and Drug Administration made public its guidance for issuing emergency approval for a Covid-19 vaccine on Tuesday, making it clear it...

Sanofi and GSK to provide 72 million vaccine doses to Canada

French pharmaceutical firm Sanofi and Britain's GSK have promised up to 72 million doses of their Covid-19 vaccine candidate to the Canadian government, which...

Sanofi halts trials of COVID-19 drug

Paris—French pharmaceutical giant Sanofi said Tuesday that international Phase 3 clinical tests of its Kevzara drug for serious Covid-19 cases had proved inconclusive and...

US doubles investment on potential virus vaccine to $1b

Washington"•The United States has doubled its investment"•to nearly $1 billion"•to expedite development of a potential COVID-19 vaccine by American firm Moderna, which on Monday...

Moderna COVID-19 vaccine enters final stage trial this month

US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, to test...

Vaccine hope and easing of lockdowns fuel Asia stocks rally

Hopes for a vaccine to treat coronavirus and a further easing of lockdown measures around the world spurred a rally on Asian markets Tuesday...
- Advertisement -spot_img
- Advertisement -spot_img